EDAP TMS S.A. (FOCL)
FOCL trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$4.20
-2.33% on the day
Market cap
$193.0M
Micro cap
Revenue · 2025
$70.5M
+1.6% on 2024
Net income · 2025
-$29.2M
-41.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | FOCL on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Country | France |
| IPO year | Not reported by the screener |
| SEC CIK | 0001041934 |
| SEC industry code | Electromedical & Electrotherapeutic Apparatus |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $70.5M |
| Net income | -$29.2M |
| Operating income | -$24.7M |
| Net margin | -41.5% |
| Operating margin | -35.0% |
| Revenue growth | +1.6% |
| Cash | $20.5M |
| Total assets | $79.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 2.7× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-08-12 |
| Latest annual report | 10-K | 2026-03-25 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report FORM 8-K | 8-K | 2026-08-19 |
| Latest proxy | DEFA14A | 2026-05-14 |
Source: SEC EDGAR submissions feed, 494 recent filings. All filings on EDGAR.
Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ELMD | Electromed Inc. | $27.68 | -1.53% | $229.4M |
| HSDT | Solana Company Class A Common Stock (DE) | $2.35 | -1.67% | $152.3M |
| VANI | Vivani Medical Inc. Common Stock (DE) | $1.18 | -0.84% | $106.4M |
| STXS | Stereotaxis Inc. | $1.06 | -7.02% | $106.2M |
| CV | CapsoVision Inc. | $6.78 | +0.30% | $360.7M |
| HYPR | Hyperfine Inc. | $0.8515 | -6.06% | $90.3M |
| NRXS | Neuraxis Inc. | $6.50 | -3.27% | $81.6M |
| OM | Outset Medical Inc. | $4.06 | +1.25% | $76.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier